Participated as a funded partner in eHealth Hub (EUR 420,688), a pan-European CSA focused on building business support infrastructure for eHealth companies.
LARDIER PASCAL
French editorial communications firm contributing to eHealth business support and health research dissemination in European H2020 consortia.
Their core work
LARDIER PASCAL, operating under the brand [ÉDITO], appears to be a French communications and editorial services firm that provides content, dissemination, and business support services to EU-funded research and health innovation projects. Their involvement in eHealth Hub — a Coordination and Support Action focused on building eHealth business support infrastructure across Europe — suggests expertise in translating complex health technologies into accessible business narratives and market-facing content. Their role in the CATCH cancer project (Marie Skłodowska-Curie Industrial Doctorate network) as a third-party partner further points to editorial or communications contributions in a research training context. The [ÉDITO] brand name (French for editorial) reinforces that their core value is professional content creation and strategic communications rather than technical research.
What they specialise in
Both CATCH (cancer connected health) and eHealth Hub involve communicating complex health and research topics to non-scientific audiences — consistent with an editorial services profile.
Participation across two different H2020 pillars (MSCA and Health) in a non-research role suggests they are brought in for professional dissemination or outreach functions.
How they've shifted over time
With only two projects, both launched in 2016, there is no meaningful timeline evolution to analyze — the entire H2020 record spans a single starting year. No keyword data is available for either project, which further limits any trend analysis. What can be said is that both engagements are in the health and research communications space, suggesting a consistent rather than evolving focus.
Too little data to identify a directional trend — both projects are from 2016 and cover the same thematic space; future collaboration signals should be validated through direct contact.
How they like to work
LARDIER PASCAL has never led an H2020 project, always entering as a participant or third-party partner. Despite this secondary role, they have engaged in relatively broad consortia — 21 unique partners across 9 countries from just two projects — suggesting they are embedded in large, multi-stakeholder networks rather than tight bilateral arrangements. This profile is typical of communications or consultancy firms that add value across many types of projects without leading them.
The organization has built connections with 21 unique consortium partners across 9 European countries — a wide reach for just two projects, suggesting their partners operate in large collaborative networks. No geographic concentration is evident from available data.
What sets them apart
LARDIER PASCAL occupies an unusual niche as a named-individual private company (not an SME by EU classification) with an editorial brand identity, operating at the intersection of health research and professional communications. For consortium builders, they offer the kind of dissemination and business support capacity that research-heavy partners often lack internally. Their value is most likely in making technical project outputs readable and actionable for non-scientific audiences — a capability that is consistently underrepresented in EU consortia.
Highlights from their portfolio
- eHealth HubThe organization's only directly funded project (EUR 420,688) — a Coordination and Support Action building pan-European business support infrastructure for eHealth companies, implying a substantial communications or programme management contribution.
- CATCHParticipation as a third-party partner in a Marie Skłodowska-Curie cancer technology training network shows cross-sector reach into academic research training, beyond pure business support.